Azitra, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AZTR NYSE American 2836 azitrainc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Azitra, Inc.

Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting - Jun 4th, 2026 2:05 pm
Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting - May 27th, 2026 2:30 pm
AZTR: More Background on Cosmetic Opportunity - May 22nd, 2026 5:15 am
Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates - May 13th, 2026 6:30 am
Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program - May 6th, 2026 6:00 am
Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris - Apr 28th, 2026 6:02 am
Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million - Mar 19th, 2026 11:13 am
Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement - Mar 13th, 2026 3:15 pm
Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders - Mar 5th, 2026 2:30 pm
AZTR: New Site for ATR-04 Trial - Mar 4th, 2026 1:00 am
Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates - Feb 27th, 2026 3:30 pm
Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash - Feb 24th, 2026 6:00 am
Azitra, Inc. to Present at BIO Investment & Growth Summit - Feb 19th, 2026 6:00 am
Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting - Feb 6th, 2026 2:15 pm
Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference - Jan 7th, 2026 6:00 am
Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American - Dec 17th, 2025 2:10 pm
Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules - Nov 24th, 2025 7:00 am
AZTR: ATR-01 Data Presented - Nov 18th, 2025 2:48 am
Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates - Nov 12th, 2025 3:15 pm
Azitra, Inc. Addresses False Report Regarding Sale of Securities - Nov 7th, 2025 4:00 am